cremophor el has been researched along with Genital Neoplasms, Female in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fransson, MN; Friberg, LE; Gréen, H; Litton, JE | 1 |
| Fransson, M; Gréen, H | 1 |
1 trial(s) available for cremophor el and Genital Neoplasms, Female
| Article | Year |
|---|---|
Comparison of two types of population pharmacokinetic model structures of paclitaxel.
Topics: Adult; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Computer Simulation; Female; Genital Neoplasms, Female; Glycerol; Humans; Middle Aged; Models, Biological; Paclitaxel; Pharmaceutical Vehicles; Reproducibility of Results | 2008 |
1 other study(ies) available for cremophor el and Genital Neoplasms, Female
| Article | Year |
|---|---|
Influence of Cremophor EL and genetic polymorphisms on the pharmacokinetics of paclitaxel and its metabolites using a mechanism-based model.
Topics: Analysis of Variance; Antineoplastic Agents, Phytogenic; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biotransformation; Chemistry, Pharmaceutical; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP3A; Drug Carriers; Female; Genital Neoplasms, Female; Glycerol; Humans; Middle Aged; Models, Biological; Paclitaxel; Polymorphism, Single Nucleotide | 2011 |